I call this meeting to order.
Welcome to meeting number 42 of the House of Commons Standing Committee on Health.
Today we meet for two hours with witnesses on our study of over-the-counter pediatric medication.
I see that we have a couple of members participating online who are well aware of the procedures and the fact that the hybrid format is permitted pursuant to the House order of June 23, 2022.
We're going to get right into welcoming the witnesses. We have a panel in front of us today who are quite familiar with the committee, as we are with them.
We have Dr. Stephen Lucas, deputy minister of Health Canada; Dr. Supriya Sharma, chief medical advisor and senior medical advisor in the health products and food branch; Stefania Trombetti, assistant deputy minister, regulatory operations and enforcement branch; Linsey Hollett, director general, health product compliance; and Dr. Kim Godard, director, health product inspection and licensing division, regulatory operations and enforcement branch.
Thank you all for being with us here today.
I understand that Dr. Lucas is going to lead us off.
You have up to five minutes, Doctor. Welcome to the committee. Thanks for being here. You have the floor.